Purple Biotech Ltd. (PPBT)
NASDAQ: PPBT · IEX Real-Time Price · USD
0.370
+0.010 (2.92%)
Jul 2, 2024, 3:59 PM EDT - Market closed
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $11.52 million as of July 2, 2024. Its market cap has decreased by -61.85% in one year.
Market Cap
11.52M
Enterprise Value
975.73K
1-Year Change
-61.85%
Ranking
Category
Stock Price
$0.37
Market Cap Chart
Since November 20, 2015, Purple Biotech's market cap has increased from $11.20M to $11.52M, an increase of 2.88%. That is a compound annual growth rate of 0.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 9.70M | -37.42% |
| Dec 29, 2023 | 15.50M | -36.99% |
| Dec 30, 2022 | 24.60M | -63.77% |
| Dec 31, 2021 | 67.90M | 805.33% |
| Dec 31, 2020 | 7.50M | -40.00% |
| Dec 31, 2019 | 12.50M | 68.92% |
| Dec 31, 2018 | 7.40M | -57.71% |
| Dec 29, 2017 | 17.50M | 44.63% |
| Dec 30, 2016 | 12.10M | 9.01% |
| Dec 31, 2015 | 11.10M | -0.89% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlucoTrack | 10.52M |
| Alaunos Therapeutics | 10.42M |
| Vaccinex | 10.33M |
| Eterna Therapeutics | 10.20M |
| Longeveron | 9.97M |
| ABVC BioPharma | 9.88M |
| NewGenIvf Group | 9.84M |
| MIRA Pharmaceuticals | 9.74M |